Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
05/2005
05/18/2005CN1617743A New pharmaceutical combinations for nos inhibitors
05/18/2005CN1617725A Tyrosyl derivatives and their use as P2X7 receptor modulators
05/18/2005CN1617666A Fused heterocyclic sulfonylurea compound, herbicide containing the same and method of controlling weed with the same
05/18/2005CN1616432A Compound, its use and pharmaceutical compositions comprising same
05/18/2005CN1616386A Intermediate for preparing isothiazole derivatives
05/18/2005CN1615873A Azaindoles compound
05/18/2005CN1202123C Crystalline forms of IS-[la(pha(2S, 3R),9alpha]-6,10-dioxo-N-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1-isoquinolyl) carbonyl]-amino] actahydro-6H-piridazino [1,2-A] [1,2] diazepin-1-carboxamide
05/18/2005CN1202109C Synthesis method of tetraalkyl tetrazaporphyrin metal coordination compound
05/18/2005CN1201821C Stable complex of insoluble chemical compound
05/18/2005CN1201740C Intermittent claudication therapeutic drugs comprising phyrroloazepines
05/17/2005US6894168 Carbamoyl tetrahydropyridine derivatives
05/17/2005US6894161 Methods and compositions for photo-cross linking photoactive compounds to target tissue
05/17/2005US6894042 Azabicyclic compounds for the treatment of disease
05/17/2005US6894021 Method for identifying and using A2B adenosine receptor antagonists to mediate mammalian cell proliferation
05/17/2005US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides
05/17/2005US6893650 Fungicides; locus infestation; such as N,N-dimethyl-N'-(4-(3-trifluoromethylbenzylthio)-2,5-xylyl)formamidine
05/17/2005CA2335492C Pyrrolo[2,3-d]pyrimidine compounds
05/12/2005WO2005042712A2 Heterocyclic compounds and methods of making and using thereof
05/12/2005WO2005042537A1 Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
05/12/2005WO2005042536A1 Novel fused polycyclic compound having heterocycle and medicinal use thereof
05/12/2005WO2005042535A1 Pyrrolobenzodiazepines
05/12/2005WO2005042534A2 A2b adenosine receptor antagonists
05/12/2005WO2005042533A2 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
05/12/2005WO2005042502A1 Amide derivatives
05/12/2005WO2005042501A1 Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
05/12/2005WO2005042475A2 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
05/12/2005WO2005041971A1 Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain
05/12/2005WO2005030131A3 Bis-quinazoline compounds for the treatment of bacterial infections
05/12/2005WO2005018531A3 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
05/12/2005WO2005003100A3 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
05/12/2005WO2005000854A3 Orally bioavailable low molecular weight metalloporphyrins as antioxidants
05/12/2005WO2004113341A3 Fungicidal triazolopyrimidines
05/12/2005WO2002094020A8 Use of triazolopyrimidine derivatives as microbicides in the protection of materials
05/12/2005US20050102596 Database mining system and method for coverage analysis of functional verification of integrated circuit designs
05/12/2005US20050101779 Antagonistic activity to alpha 4 integrin; antiinflammatory agents treating asthma, rheumatoid arthritis, inflammatory bowel diseases, lupus, diabetes; 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1-methyl-2,4-dioxo-1,4-tetrahydro-3-(2H)quinazolinyl]phenyl]Propionate
05/12/2005US20050101644 Benzylether amine compounds useful as CCR-5 antagonists
05/12/2005US20050101634 Bis(5-aeyl-2-pyridyl) derivatives
05/12/2005US20050101614 Heterocyclic GABAA subtype selective receptor modulators
05/12/2005US20050101604 For therapy of cancer, including of breast neoplasma, endometrial cancer, colon cancer, and neck squamous cell carcinoma and of autoimmune diseases
05/12/2005US20050101603 Compound and method for the treatment of pain
05/12/2005US20050101594 Compositions useful as inhibitors of protein kinases
05/12/2005US20050101593 Phosphoric acid salt of an integrin receptor antagonist
05/12/2005US20050101592 3-(4-chlorophenyl)-2-(2-chlorophenyl)-7-(2,2,2-trifluoroethyl)-6,7-dihydro-2H,5H-4-oxa-1,2,7-triaza-azulen-8-one; for treatment of disorders linked to mediation of cannabinoid receptors
05/12/2005US20050101588 7-Amino alkylidenyl-heterocyclic quinolones and naphthyridones
05/12/2005CA2544310A1 New fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof
05/12/2005CA2543710A1 Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
05/12/2005CA2543533A1 2-cyanopyrrolidinecarboxamide compound
05/12/2005CA2543322A1 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
05/12/2005CA2542536A1 Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain
05/12/2005CA2542047A1 Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors
05/12/2005CA2540460A1 Heterocyclic compounds and methods of making and using thereof
05/11/2005EP1529044A2 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
05/11/2005EP1397363B1 5-ethyl-imidazotriazinones
05/11/2005EP1363899B1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
05/11/2005EP0973752B1 Heterocyclically substituted aromatic amino compounds with a herbicidal effect
05/11/2005CN1615306A C-5 modified indazolylpyrrolotriazines
05/11/2005CN1615303A Improved purification of 4, 4'(5')-di-t-butylcyclohexano-18-crown-6
05/11/2005CN1615299A Xanthine oxidase inhibitors
05/11/2005CN1615129A Process for affecting neurologic progression
05/11/2005CN1201201C Colour coupler and silver halide colour photographic photosensitive material
05/11/2005CN1200940C Triazole pyrimidine compounds
05/10/2005US6891071 Halogenated styrene compounds and very low-loss polymers made therefrom
05/10/2005US6891067 Optical polyimide precursor, optical polyimide compound and fabricating method thereof
05/10/2005US6890977 Use of certain 3,6-diaryl-1,4-diketopyrrolo(3,4-c)pyrrole pigments in colorants which can be used to pigment plastics in the injection molding process; dimensional stability
05/10/2005US6890938 Antiinflammatory agents
05/10/2005US6890935 Pharmaceutical compositions and methods for use
05/10/2005US6890929 Immunosuppressants; lupus, multiple sclerosis, skin disorders, antiarthritic agents, antihistamines, antiulcer agents, Crohn's disease
05/10/2005US6890927 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
05/10/2005US6890922 For treatment of erectile dysfunction as well as female sexual dysfunction, incontinence, and hypertrophy of the prostate; inhibitors of cGMP-metabolizing phosphodiesterases (cGMP= cyclic guanosine monophosphate)
05/10/2005US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
05/10/2005CA2191815C Heterocyclic compounds having tachykinin receptor antagonist activity, their preparation and their use
05/06/2005WO2005040173A1 Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors
05/06/2005WO2005040172A1 Tricyclic proline derivative
05/06/2005WO2005040171A1 Pyrazolo and imidazo-pyrimidine derivatives
05/06/2005WO2005040170A2 Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto
05/06/2005WO2005040169A2 Fused heterocyclic compounds as serotonin receptor modulators
05/06/2005WO2005040163A1 Heterocyclic compounds that block the effects of advanced glycation end products (age)
05/06/2005WO2005040160A2 Processes for preparation of ziprasidone
05/06/2005WO2005039564A1 Phthalimide compounds useful as protein kinase inhibitors
05/06/2005WO2005039486A2 Compounds and compositions as protein kinase inhibitors
05/06/2005WO2005039484A2 Indolocarbazole anticancer agents and methods of using same
05/06/2005WO2005023812A3 Piperazines as oxytocin agonists
05/06/2005WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
05/06/2005CA2782783A1 Fused heterocyclic compounds
05/06/2005CA2543805A1 Processes for preparation of ziprasidone
05/06/2005CA2543318A1 Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto
05/06/2005CA2540817A1 Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors
05/06/2005CA2536535A1 Compounds and compositions as protein kinase inhibitors
05/05/2005US20050096387 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
05/05/2005US20050096333 Quinazoline derivatives as medicaments
05/05/2005US20050096331 Alkyl carboxylic acids and their derivatives; antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic compounds; better efficacy, potency and lower toxicity
05/05/2005US20050096327 eg 2-(4-Methyl-piperazin-1-yl)-4-phenyl-quinazoline; attention deficit hyperactivity disorder
05/05/2005US20050096322 Nitrogen-containing heterocyclic compound
05/05/2005US20050096321 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates
05/05/2005US20050096320 potent inhibitors of cyclic guanosine 3',5'-monophosphate-metabolizing phosphodiesterases (cGMP-PDEs)/phosphodiesterase isoenzymes PDE-I, PDE-II, PDE-V; therapeutic, antiaggregatory, antithrombotic, antiproliferative, antivasospastic, vasodilatory, natriuretic and diuretic effects; erectile dysfunction
05/05/2005US20050096298 Purine compounds for treatment of bone disorders or cancer
05/04/2005EP1528062A2 Process for the preparation of s-type 4-substituted hydroxypyranoindolidine compounds
05/04/2005EP1527077A2 Pyrrolopyrazines as kinase inhibitors
05/04/2005EP1527075A1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands
05/04/2005EP1527074A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
1 ... 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 ... 573